ResMed Inc. RMD NYSE

ResMed Inc. (RMD) reported total assets of $8.17B and total liabilities of $2.21B for fiscal year 2025, resulting in total equity of $5.97B.

The company held $1.21B in cash and short-term investments. Total debt stood at $851.81M, with net debt of $-357.64M. The Debt-to-Equity (D/E) ratio was 0.14 (conservative).

Current ratio is 3.44, indicating strong short-term liquidity. Interest coverage is 133.7x (strong).

Criteria supported by this page:

• HEALTH (100/100, Pass) — Debt-to-Equity of 0.14, current ratio of 3.44, interest coverage 133.7x — balance sheet is strong
• MOAT (80/100) — Total assets $8.17B and equity $5.97B support the company's competitive scale
• VALUE (48/100) — Debt-to-Equity 0.14 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 78/100 with 5/7 criteria passed.

BDX

Becton, Dickinson and Company

$155.73

+0.19%

CAH

Cardinal Health, Inc.

$214.95

+0.36%

HLN

Haleon plc

$9.70

-1.32%

ALC

Alcon Inc.

$79.94

+0.25%

GEHC

GE HealthCare Technologies Inc.

$74.67

+1.14%

A

Agilent Technologies, Inc.

$120.40

+2.47%

INSM

Insmed Incorporated

$153.40

+1.50%

IQV

IQVIA Holdings Inc.

$175.28

+1.91%